Management

Expertise, insight and commitment to deliver on strategy

Opus’ core team has an ideal mix of experience in science, company formation, patient advocacy, financing and gene therapy drug development. 

Management

Ben Yerxa, PhD
President & CEO
Ash Jayagopal, PhD
Chief Scientific Officer
Sarah Tuller, JD, RAC
Chief Regulatory Officer